How Metastasis Works

Every tissue in your body is held together by an extracellular matrix—a mesh of proteins like collagen and laminin that acts like biological rebar, giving tissues their structure and keeping cells in their proper places. Cancer cells break free by secreting enzymes called matrix metalloproteinases that chew through this scaffolding like molecular scissors cutting through rope. This enzymatic assault creates pathways through which cancer cells can squeeze and migrate.

The invasion process also requires cancer cells to change shape. Normal cells are anchored to their neighbors and the surrounding matrix through protein connections called adhesion molecules. Metastatic cancer cells loosen these connections by reducing E-cadherin, the molecular glue that binds epithelial cells together, while increasing integrins that help them grip and crawl. This transformation allows cells to adopt an elongated, mobile shape—much like a person squeezing through a tight space by turning sideways.

As cancer cells push through tissue barriers, they often recruit help from the body's own cells. They send chemical signals that attract immune cells and fibroblasts, which then secrete additional matrix-degrading enzymes. This collaborative destruction creates highways through normal tissue, sometimes called "invasion tracks," that trailing cancer cells can follow more easily.

To metastasize, cancer cells must cross into the circulatory system—either blood vessels or lymphatic vessels that drain fluid from tissues. This process, called intravasation, requires breaching the vessel wall, which consists of a layer of endothelial cells sitting on a basement membrane. Cancer cells use the same matrix-degrading enzymes from invasion to dissolve this basement membrane, creating entry points into the vessel.

Blood vessel walls near tumors are often already compromised. Tumors secrete vascular endothelial growth factor (VEGF), which triggers rapid formation of new blood vessels through a process called angiogenesis. These tumor-induced vessels are poorly constructed—leaky, with gaps between endothelial cells and thin or absent basement membranes. Cancer cells exploit these structural weaknesses, slipping through gaps that wouldn't exist in healthy vessels.

The entry process can be surprisingly mechanical. As tumors grow, they create physical pressure on surrounding tissues. Cancer cells at the tumor's edge may be squeezed into nearby vessels like toothpaste through a tube. Once inside, they're swept into circulation, beginning their journey to distant sites.

Once inside vessels, cancer cells face a harrowing journey. In the bloodstream, they encounter shear forces from rapid blood flow that can tear cells apart—it's like being caught in a raging river. They also become targets for the immune system, particularly natural killer cells that patrol for abnormal cells. Studies show that fewer than 0.01% of cancer cells that enter circulation survive to form metastases; the vast majority die within minutes to hours.

To improve their odds, many cancer cells travel in clusters or clump together with blood platelets—the cell fragments involved in clotting. Platelets form a protective coating around cancer cells, shielding them from immune attack and from the physical stresses of circulation. These platelet-cloaked clusters are more likely to survive and successfully establish metastases than individual cancer cells traveling alone.

Cancer cells may circulate for hours to weeks, traveling through the heart and lungs repeatedly before exiting elsewhere. The lymphatic system offers a gentler alternative—lymph moves more slowly and with less turbulence than blood. Cancer cells that enter lymphatic vessels often reach nearby lymph nodes first, where they may establish secondary tumors before continuing to more distant sites through connections between lymphatic and blood circulation.

To leave the bloodstream and invade a new organ, cancer cells must reverse the entry process—a step called extravasation. This often begins with arrest: cancer cells or cell clusters become physically lodged in small capillaries whose diameter is narrower than the cell itself. In organs with particularly narrow capillaries, like the lungs and liver, this physical trapping is a major reason these organs are common metastatic sites.

Arrest alone isn't enough; the cancer cell must actively exit the vessel. Lodged cells extend protrusions through gaps between endothelial cells or directly through individual endothelial cells themselves. They secrete enzymes to digest the capillary basement membrane from the inside out. Meanwhile, they release inflammatory signals that cause endothelial cells to retract from one another, widening the gaps and making escape easier.

The organ environment influences whether cancer cells successfully exit. Some organs, like bone marrow and liver, have naturally fenestrated (porous) capillaries that cancer cells penetrate more easily. Others, like the brain, have tightly sealed vessels forming the blood-brain barrier, making extravasation more difficult—which partly explains why brain metastases, while serious, are less common than metastases to organs with leakier vessels.

Exiting the bloodstream into a new organ is just the beginning; colonization—establishing a growing tumor—is the rate-limiting step of metastasis. Most cancer cells that successfully extravasate still fail to thrive. They've arrived in a foreign microenvironment with different nutrients, oxygen levels, and cellular neighbors than their tissue of origin. Many enter dormancy, surviving as isolated cells for months, years, or even decades without growing. Some eventually die; others reawaken under conditions scientists are still working to understand.

Successful colonizers must co-opt their new environment. They recruit local blood vessels to supply oxygen and nutrients to the growing colony, just as the primary tumor did. They manipulate nearby stromal cells—the supporting cast of fibroblasts, immune cells, and other residents—into providing growth factors and creating a supportive niche. In bone, for instance, breast cancer cells hijack the normal bone remodeling process, stimulating bone-dissolving cells to release calcium and growth factors that feed the metastasis.

The concept of "seed and soil" explains why cancers show organ-specific metastatic patterns. Breast cancer commonly spreads to bone, liver, lung, and brain, while prostate cancer favors bone. This selectivity isn't random—certain cancer cells (seeds) thrive only in certain organ microenvironments (soil). Matching factors include the expression of adhesion molecules that let cancer cells dock to specific organs, and the presence of growth factors in target organs that happen to stimulate receptors the cancer cells carry from their tissue of origin.